Pfizer vet to lead 1 new phase 3-ready biotech as CEO
A long-time Pfizer vet has been appointed CEO of a newly formed biotech company. The firm is already poised to enter phase 3 trials for its lead candidate.
pfizer vet
Read More
February 8, 2026